Drug Master Files for: RIVAROXABAN
✉ Email this page to a colleague
RIVAROXABAN Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
21580 | A | II | 7/23/2008 | BAYER AG | RIVAROXABAN COATED TABLETS, 10 MG |
21581 | A | II | 7/23/2008 | BAYER AG | RIVAROXABAN (MICRONIZED) DRUG SUBSTANCE |
21592 | A | II | 7/24/2008 | JANSSEN ORTHO LLC | RIVAROXABAN 10 MG FILM COATED TABLETS |
27661 | A | II | 10/21/2013 | ZAKLADY FARMACEUTYCZNE POLPHARMA SA | RIVAROXABAN |
27807 | A | II | 12/31/2013 | MSN LABORATORIES PRIVATE LTD | RIVAROXABAN [ROUTE CODE - 'RR'] |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information